. 2022 Jul 2;15(7):100658. doi: 10.1016/j.waojou.2022.100658

Table 2.

Reports of suspected adverse drug reactions involving fexofenadine.

Year	Age	Sex	Suspected drug	Therapeutic indication for fexofenadine	Adverse reaction
2011	70	Female	Fexofenadine Paroxetine Atenolol Ramipril Delorazepam Simvastatin Ezetimibe	Allergic reaction	Retrograde Amnesia^a, Bradyphrenia^a, Psychomotor Retardations^a, Abnormal Behaviour^a, Sleepiness, Disorientation, Agitation
2015	36	Female	Fexofenadine Desometasone/Tobramycin	Not specified	Ocular oedema, Labial oedema
2017	29	Male	Fexofenadine	Allergic rhinitis	Glomerulonephritis^a, Weight increase^a
2017	21	Female	Fexofenadine	Allergic rhinitis	Chest oppression, Tachycardia, Throat constriction
2018	30	Female	Fexofenadine	Not specified	Anxiety^a, Diarrhoea^a, Insomnia^a, Nervousness, Nightmares, Tachycardia
2018	23	Female	Fexofenadine	Seasonal allergy	Dry mouth^a, Flush^a, Palpitation, Pharynx Oedema, Tongue oedema
2019	22	Female	Fexofenadine	Allergic reaction	Sense of oppression, Tachycardia
2019	16	Female	Fexofenadine Cetirizine	Not specified	Depression^a, Misuse^a, Mania^a, Panic Attack^a, Event not evaluable^a

Cases are listed chronologically according to year the report was submitted to the FDA.

FDA, food and drug administration.

Unexpected events